We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

34 hedge funds and large institutions have $7.3M invested in OncoSec Medical Incorporated in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

316% more capital invested

Capital invested by funds: $1.75M → $7.3M (+$5.54M)

280% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 5

70% more funds holding

Funds holding: 20 → 34 (+14)

Holders
34
Holders Change
+14
Holders Change %
+70%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.47M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$524K
3
CLCM
Crawford Lake Capital Management
New Jersey
+$472K
4
Renaissance Technologies
Renaissance Technologies
New York
+$266K
5
Deutsche Bank
Deutsche Bank
Germany
+$256K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.36M
2
VF
Virtu Financial
New York
-$46K
3
Citadel Advisors
Citadel Advisors
Florida
-$27K
4
SMH
Sanders Morris Harris
Texas
-$24K
5
TSS
Two Sigma Securities
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$3.54M +$3.47M +9,909 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.28M +$524K +1,496 +72%
CLCM
3
Crawford Lake Capital Management
New Jersey
$482K +$472K +1,348 New
Renaissance Technologies
4
Renaissance Technologies
New York
$272K +$266K +760 New
Deutsche Bank
5
Deutsche Bank
Germany
$261K +$256K +731 New
SM
6
Sabby Management
Florida
$249K -$1.36M -3,896 -85%
JGC
7
J. Goldman & Co
New York
$163K +$159K +455 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$158K +$154K +441 New
Zurich Cantonal Bank
9
Zurich Cantonal Bank
Switzerland
$150K – – –
MA
10
MYDA Advisors
New York
$145K +$142K +405 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$92K – – –
Northern Trust
12
Northern Trust
Illinois
$92K +$52.5K +150 +140%
Millennium Management
13
Millennium Management
New York
$75K +$73.2K +209 New
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$63K +$61.7K +176 New
FAAS
15
First Allied Advisory Services
California
$58K – – –
Barclays
16
Barclays
United Kingdom
$46K +$44.5K +127 New
Creative Planning
17
Creative Planning
Kansas
$31K +$30.8K +88 New
Wells Fargo
18
Wells Fargo
California
$27K +$26.3K +75 New
BlackRock
19
BlackRock
New York
$25K +$701 +2 +3%
Northwestern Mutual Wealth Management
20
Northwestern Mutual Wealth Management
Wisconsin
$18K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$18K +$701 +2 +4%
AG
22
Advisor Group
Arizona
$12K +$11.2K +32 New
FMA
23
FNY Managed Accounts
New York
$8K +$8.06K +23 New
Macquarie Group
24
Macquarie Group
Australia
$8K +$8.06K +23 New
CHP
25
Cable Hill Partners
Oregon
$6K +$4.9K +14 New
1
2

ONCS Hedge Fund Activity: Q4 2017 in Review

34 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2017, worth a combined $7.3M — up 316% from $1.75M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ONCS positions and 5 closed out — a net gain of 14 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.47M. The largest seller was Sabby Management, cutting an estimated $1.36M.

  • 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2017, up from 20 in Q3 2017.
  • Funds reported $7.3M of OncoSec Medical Incorporated stock for Q4 2017, up 316% quarter-over-quarter.
  • 19 funds opened new OncoSec Medical Incorporated positions in Q4 2017 and 5 closed out, a net change of +14 holders.
  • The largest OncoSec Medical Incorporated buyer in Q4 2017 was Point72 Asset Management, an estimated $3.47M added.
  • The largest OncoSec Medical Incorporated seller in Q4 2017 was Sabby Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2017.